期刊文献+

疏血通注射液治疗紫癜性肾病100例临床分析 被引量:1

Clinical study of Shuxuetong injection in the treatment of nephrotic syndrome caused by anaphylactoid purpura
下载PDF
导出
摘要 目的:探讨疏血通注射液治疗儿童过敏性紫癜(AP)引起的肾病综合征的临床疗效。方法:100例紫癜性肾病患儿随机分为治疗组和对照组,两组各50例。均以强的松中长程治疗。治疗组同时应用疏血通注射液21d,观察4—6周并随访。治疗前后分别测量血脂、肾功能、血流变学等各项有关指标,并记录治疗后两组患儿血压、浮肿、蛋白尿、血尿、β2-MG恢复正常的时间。结果:治疗组治疗前后及两组治疗后尿素氮、肌苷、胆固醇、甘油三脂、血浆粘度、血小板聚集率及红细胞电泳时间比较差异有统计学意义(P〈0.05);两组的红细胞压积比比较差异无统计学意义(P〉0.05);血沉下降,两组间差异无统计学意义(P〉0.05);血压、浮肿、蛋白尿、血尿、β2-MG恢复正常的时间治疗组和对照组比较有统计学意义(P〈0.05)。结论:疏血通注射液治疗紫癜性肾病疗效好,能缩短病程,提高治愈率,值得临床推广应用。 Objection To investigate the therapeutic effect of Shuxuetong injection in the treatment of nephrotic syndrome caused by anaphylactoid purpura (AP). Method One hundrand children suffering from nephrotic syndrome caused by AP were divided into two groups as the experimental group and the control group randomly, with 50 cases in each group. The two groups were both treated with prednisene and additional treatment of Shuxuetong were administrated in the experimental group for 21 days. The two groups were followed up for 4 - 6 weeks. Changes of blood lipid, renal function and hemorheology were detected by relevant methods and the time spans of symptoms such as blood pressure, edema, albuminuria, bematuria and microglobulin became normal were registered. Results Blood urea nitrogen, inosine, cholesterol, triglyceride, blood viscosity, platelet aggregation rate and erythrocyte electrophoresis time showed significant difference between the two groups after treatment and pre - and post - treatment in the experimental group (P 〈 0.05), while the differences of the packed cellvolume and erythrocutes sedimentation rate between the two groups had no statistic meanings ( P 〉 0.05 ). The differences of recovery time in the two groups were significant ( P 〈 0.05 ). Conclusion Shuxuetong injection is effective in the treatment of nephrotic syndrome caused by AP by improving the curative rate and lessening hospitalized time.
作者 郭静
出处 《吉林医学》 CAS 2008年第1期8-10,共3页 Jilin Medical Journal
关键词 疏血通注射液 过敏性紫癜 肾病综合证 Shuxuetong injection Anaphylactoid purpura Nephrotic syndrome
  • 相关文献

参考文献4

  • 1姜新猷 陈荣华 王宝琳.关于小儿肾小球临床分类和治疗的修订意见[J].中华儿科杂志,1981,19(4):241-242.
  • 2张欣.小儿过敏性紫癜性肾炎31例临床分析[J].临床儿科杂志,1986,4(1):22-23.
  • 3左启华.儿科学[M].第3版.北京:人民卫生出版社,1993.285
  • 4马培志,邵凤民.蚯蚓提取物对原发性肾病综合征患者凝血系统的影响[J].中国中西医结合肾病杂志,2002,3(9):528-529. 被引量:20

二级参考文献10

  • 1朱长连,王小阳,张国桢,孙丽云.蚯蚓提取物的纤溶和抗凝作用[J].河南医科大学学报,1993,28(1):15-17. 被引量:26
  • 2Rober A,Kitera J,Broteory EG,et al.Clinical correlation between hypercoagulability and thromboetic phenomenon.Thromb Res,1994,74:125-131.
  • 3Levin EG,Naragaj GR,Takiee T,et al.Latent tissue plasminogen activator produced by human endothelial cells in culture:Evidence for an enzymeinhibitor complex.Proc Natl Acad Sci USA,1996,93:6804-6809.
  • 4Kruithof EKO,Gubrabi TD,Hunter I, et al.Demonstration of a fastacting inhibitor of plasminogen activators in human plasma.Blood,1994,84:1907-1911.
  • 5Wimah B,Mecham RP,Mayer V. The role of the fibrinolytic system in deep vein thrombosis.J Lab Clin Med,1995,135:365-372.
  • 6Nilsson IM,Nisch R,Fox JW,et al.Two different mechanisms in patients with venous thrombosis and defective fibrinolysis:Low concentration of plasminogen activator of increased concentration of plasminogen activator inhibitor.Br Med J,1995,310:2053-2065.
  • 7Tomura S,Nakamura Y,Deguchi F,et al.Coagulation and fibrinolysis in patients with chronic renal failure and undergoing conservative treatment.Thromb Res,1991,64:81-89.
  • 8Park K ,Kye C,Lee M,et al.Fibrinolytic activity of the earthworm extract.Thomb Haemost,1989,62(1):689-692.
  • 9Mihara H,Killem PD,Takemura T,et al.Thrombolytic proteases from earthworm.Eur pat Appl,1984,82:92-105.
  • 10Mihara H,Fine LJ,Okuda S,et al.A Possibility of earthworm powder as therapeutic agent for thrombosis.Thromb Haemost,1989,62(1):545-548.

共引文献24

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部